Designing orodispersible films containing everolimus for enhanced compliance and bioavailability.

Ma, Yidi; Guan, Rou; Gao, Shuying; Song, Wei; Liu, Yubo; Yang, Yang; Liu, Hongzhuo

Ma, Yidi; Guan, Rou; Gao, Shuying; Song, Wei; Liu, Yubo; Yang, Yang; Liu, Hongzhuo.

Afiliação

Ma Y; Wuya College of Innovation, Shenyang Pharmaceutical University , Shenyang, China.
Guan R; Wuya College of Innovation, Shenyang Pharmaceutical University , Shenyang, China.
Gao S; Wuya College of Innovation, Shenyang Pharmaceutical University , Shenyang, China.
Song W; Wuya College of Innovation, Shenyang Pharmaceutical University , Shenyang, China.
Liu Y; Wuya College of Innovation, Shenyang Pharmaceutical University , Shenyang, China.
Yang Y; College of Pharmacy, Shenyang Pharmaceutical University , Shenyang, China.
Liu H; Wuya College of Innovation, Shenyang Pharmaceutical University , Shenyang, China.

Expert Opin Drug Deliv ; 17(10): 1499-1508, 2020 10.

Article em En | MEDLINE | ID: mdl-32975132

Assuntos

Everolimo/administração & dosagem; Cooperação do Paciente; Administração Sublingual; Animais; Disponibilidade Biológica; Varredura Diferencial de Calorimetria; Masculino; Ratos; Ratos Sprague-Dawley; Solubilidade; Solventes/química; Água/química; Difração de Raios X

Palavras-chave

Acacia gum; everolimus; oral bioavailability; orodispersible film; patient compliance; stability

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cooperação do Paciente / Everolimo Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google